Notes - Segment Information, Etc.

TAIKO PHARMACEUTICAL CO., LTD. - Filing #7270730

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
508,000,000 JPY
6,292,000,000 JPY
5,000,000 JPY
5,778,000,000 JPY
JPY
6,292,000,000 JPY
6,120,000,000 JPY
929,000,000 JPY
5,185,000,000 JPY
5,000,000 JPY
JPY
6,120,000,000 JPY
Transactions with other segments
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Other items
Depreciation
12,000,000 JPY
256,000,000 JPY
JPY
220,000,000 JPY
24,000,000 JPY
232,000,000 JPY
704,000,000 JPY
44,000,000 JPY
525,000,000 JPY
JPY
135,000,000 JPY
569,000,000 JPY
Increase in property, plant and equipment and intangible assets
4,000,000 JPY
209,000,000 JPY
JPY
137,000,000 JPY
67,000,000 JPY
142,000,000 JPY
258,000,000 JPY
89,000,000 JPY
101,000,000 JPY
JPY
68,000,000 JPY
190,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.